MTOR and acute lymphoblastic leukemia: In the current study, we examined the effects of two drugs, one directed against the PI3-kinase/mTOR pathway (BEZ235) and the other directed against several different anti-apoptotic members of the BCL-2 family (obatoclax), on growth and survival of ALL cells.